Base-native attestation and verification infrastructure for real-world integrity events.
QEVX Protocol — Quality Evidence Verification X — is a proposed Base-native protocol for attesting and verifying real-world integrity events. Its first use case is NCISA’s healthcare discrepancy-detection workflow, but it is designed to support repeatable onchain usage across verification, audit access, APIs, payments, AI-agent verification workflows, and future financial-integrity and compliance workflows.
The “X” represents the cross-system, cross-organization, and cross-sector verification layer that turns real-world integrity events into Base-native attestations and verification activity.
What is QEVX?
First Use Case: NCISA
NCISA identifies clinically meaningful healthcare information discrepancies that may contribute to iatrogenic risk during transitions of care and other high-risk workflows.
NCISA detects the discrepancy. QEVX structures the integrity event. A cryptographic proof can be generated and attested on Base. Authorized parties can later verify that the record still matches the original proof.
No protected healthcare information is placed onchain.
Why Base
QEVX is being designed for Base because integrity events can become repeatable onchain activity. Potential protocol activity may include event registration, Base-native attestations, verification requests, audit access, API usage, AI-agent verification workflows, and future utility-layer participation.
Token Status
No QEVX token has been deployed.
Any future token name, symbol, or ticker will be finalized following legal, trademark, and Base ecosystem review.
QEVX is focused first on proving the infrastructure, utility model, security requirements, compliance pathway, product-market fit, and Base ecosystem fit before any mainnet token deployment or public token activity.
Current Development
NCISA is supported by an active academic research collaboration with Vanderbilt University. An NIH R21 application has been submitted through Vanderbilt University relating to clinically meaningful discrepancy and transitions-of-care research. The Joint Commission has requested updates as this work progresses.
These references should not be understood as endorsement of QEVX, any token, or any commercial blockchain project by Vanderbilt University, NIH, or The Joint Commission.
Contact:
contact@qevx.tech
© 2026. All rights reserved.
